Abstract 98: Hirsutism under evaluation

por Harshita, B, Selvan, Chitra
Publicado 2022

Oral and oropharyngeal high-risk HPV prevalence, HIV status, and risk behaviours in a cohort of South African men who have sex with men

por Mistry, Harshita B, Lebelo, Ramokone L, Matshonyonge, Fulufhelo, Nchabeleng, Maphoshane, Mathebula, Matsontso, Bogers, John-Paul, Wood, Neil H
Publicado 2021

Understanding the Intricate Web of Phytohormone Signalling in Modulating Root System Architecture

por Sharma, Manvi, Singh, Dhriti, Saksena, Harshita B., Sharma, Mohan, Tiwari, Archna, Awasthi, Prakhar, Botta, Halidev Krishna, Shukla, Brihaspati Narayan, Laxmi, Ashverya
Publicado 2021

PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic manner

por Wu, Bogang, Sun, Xiujie, Yuan, Bin, Ge, Fei, Gupta, Harshita B., Chiang, Huai-Chin, Li, Jingwei, Hu, Yanfen, Curiel, Tyler J., Li, Rong
Publicado 2020

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer

por Gupta, Harshita B, Clark, Curtis A, Yuan, Bin, Sareddy, Gangadhara, Pandeswara, Srilakshmi, Padron, Alvaro S, Hurez, Vincent, Conejo-Garcia, José, Vadlamudi, Ratna, Li, Rong, Curiel, Tyler J
Publicado 2016

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer

por Wu, Bogang, Sun, Xiujie, Gupta, Harshita B., Yuan, Bin, Li, Jingwei, Ge, Fei, Chiang, Huai-Chin, Zhang, Xiaowen, Zhang, Chi, Zhang, Deyi, Yang, Jing, Hu, Yanfen, Curiel, Tyler J., Li, Rong
Publicado 2018

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

por Zhang, Deyi, Reyes, Ryan M., Osta, Erica, Kari, Suresh, Gupta, Harshita B., Padron, Alvaro S., Kornepati, Anand V. R., Kancharla, Aravind, Sun, Xiujie, Deng, Yilun, Wu, Bogang, Vadlamudi, Ratna, Li, Rong, Svatek, Robert S., Curiel, Tyler J.
Publicado 2021

Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer

por Yuan, Bin, Cheng, Long, Gupta, Kshama, Chiang, Huai-Chin, Gupta, Harshita B., Sareddy, Gangadhara R., Wang, Degeng, Lathrop, Kate, Elledge, Richard, Wang, Pei, McHardy, Stanton, Vadlamudi, Ratna, Curiel, Tyler J., Hu, Yanfen, Ye, Qinong, Li, Rong
Publicado 2016

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive th...

por Bai, Haiyan, Padron, Alvaro S, Deng, Yilun, Liao, Yiji J, Murray, Clare J, Ontiveros, Carlos, Kari, Suresh J, Kancharla, Aravind, Kornepati, Anand V R, Garcia, Myrna, Reyes, Ryan Michael, Gupta, Harshita B, Conejo-Garcia, Jose R, Curiel, Tyler
Publicado 2023

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

por Reyes, Ryan Michael, Deng, Yilun, Zhang, Deyi, Ji, Niannian, Mukherjee, Neelam, Wheeler, Karen, Gupta, Harshita B, Padron, Alvaro S, Kancharla, Aravind, Zhang, Chenghao, Garcia, Myrna, Kornepati, Anand V R, Boyman, Onur, Conejo-Garcia, Jose R, Svatek, Robert S, Curiel, Tyler J
Publicado 2021

DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo

por Naumann, Jordan A., Argyris, Prokopios P., Carpenter, Michael A., Gupta, Harshita B., Chen, Yanjun, Temiz, Nuri A., Zhou, Yufan, Durfee, Cameron, Proehl, Joshua, Koniar, Brenda L., Conticello, Silvestro G., Largaespada, David A., Brown, William L., Aihara, Hideki, Vogel, Rachel I., Harris, Reuben S.
Publicado 2023